SELLAS Life Sciences Group, Inc. (SLS)
1.92
+0.02
(+1.05%)
USD |
NASDAQ |
Dec 10, 14:33
SELLAS Life Sciences Group EPS Diluted (Quarterly): -0.0626 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Geron Corp. | -0.0276 |
| GT Biopharma, Inc. | -0.8268 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.791M |
| Total Expenses (Quarterly) | 6.791M |
| Enterprise Value | 226.82M |
| Earnings Yield | -14.94% |
| Normalized Earnings Yield | -14.94 |